extensive stage small cell lung carcinoma
Showing 1 - 10 of 10
Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma Trial in Canada, United States (3-Dimensional
Active, not recruiting
- Extensive Stage Small Cell Lung Carcinoma
- Limited Stage Small Cell Lung Carcinoma
- 3-Dimensional Conformal Radiation Therapy
- +4 more
-
Birmingham, Alabama
- +282 more
Nov 1, 2022
Extensive Stage Small Cell Lung Carcinoma Trial in United States (Pembrolizumab, Laboratory Biomarker Analysis)
Active, not recruiting
- Extensive Stage Small Cell Lung Carcinoma
- Pembrolizumab
- Laboratory Biomarker Analysis
-
Chicago, Illinois
- +4 more
Jun 28, 2022
Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,
Recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +7 more
- Auranofin
- +3 more
-
Scottsdale, Arizona
- +1 more
Jun 27, 2022
Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,
Active, not recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +2 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma Trial in United States (drug, biological, other)
Completed
- Extensive Stage Small Cell Lung Carcinoma
- Recurrent Small Cell Lung Carcinoma
- Cisplatin
- +4 more
-
Scottsdale, Arizona
- +300 more
Dec 10, 2020
Extensive Stage Small Cell Lung Carcinoma Trial in Nashville (procedure, device, other)
Terminated
- Extensive Stage Small Cell Lung Carcinoma
- Tumor Treating Fields (TTF) Therapy
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jul 17, 2020
Extensive Stage Small Cell Lung Carcinoma Trial in United States (LY2510924, Carboplatin, Etoposide)
Completed
- Extensive Stage Small Cell Lung Carcinoma
- LY2510924
- +2 more
-
Denver, Colorado
- +14 more
Jun 28, 2019
Extensive Stage Small Cell Lung Carcinoma, Large Cell Lung Carcinoma, Neuroendocrine Carcinoma Trial in United States
Completed
- Extensive Stage Small Cell Lung Carcinoma
- +4 more
- Cisplatin
- +3 more
-
Loma Linda, California
- +427 more
Jan 17, 2019
Extensive Stage Small Cell Lung Carcinoma Trial in Duarte, South Pasadena, Boston (biological, drug, other)
Withdrawn
- Extensive Stage Small Cell Lung Carcinoma
- Pembrolizumab
- +2 more
-
Duarte, California
- +2 more
Oct 8, 2018